Amphastar Pharmaceuticals AMPH Q1 2026 Earnings EPS Misses Estimates by 416 as Stock Edges Higher ADAML Q1 2026 Earnings Preferred EPS Crushes Estimates by 75 as FixedtoFloating Rate Structure Gains Traction NU Q1 2026 Earnings EPS Misses Estimates Stock Declines on Profitability Concerns RPAY Q1 2026 Earnings EPS Beat Drives Positive Market Reaction ABEO Q1 2026 Earnings NarrowerthanExpected Loss Bolstered by Cost Management BSRR Q1 2026 Earnings EPS Beat of 1438 Overshadowed by Slight Stock Decline